Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01721577
Title Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
Acronym AXL1717
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rush University Medical Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.